Purpose
Compliant version of the Adult Immunization Schedule by Medical Condition and Other Indication.
Ages 19 Years or Older
< < Back to Adult Immunization Schedule by Medical Condition
¶ = Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
§ = Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
^ = Recommended based on shared clinical decision-making
| = Recommended for all adults, and additional doses may be necessary based on medical condition or other indications. See Notes.
± = Precaution: Might be indicated if benefit of protection outweighs risk of adverse reaction
# = Contraindicated or not recommended *Vaccinate after pregnancy, if indicated
• = No Guidance/Not Applicable
Vaccine | Pregnancy | Immuno-compromised (excluding HIV infection) |
HIV infection CD4 percentage and count |
Men who have sex with men | Asplenia, complement deficiency | Heart or lung disease | Kidney failure, End-stage renal disease or on dialysis | Chronic liver disease; alcoholisma | Diabetes | Health care Personnelb | |
---|---|---|---|---|---|---|---|---|---|---|---|
<15% or <200mm3 | ≥15% and ≥200mm3 | ||||||||||
COVID-19 | ¶ | See Notes| | ¶ | ¶ | |||||||
Influenza inactivated Influenza recombinant |
¶ | Solid organ transplant (See Notes)¶ |
1 dose annually¶ | ||||||||
LAIV3 | # | 1 dose annually if age 19–49 years§ |
# | 1 dose annually if age 19– | 49 years±§ | ||||||
RSV | Seasonal administration. (See Notes)¶ | See Notes§ | § | See notes§ |
Liver disease
(See Notes)§ |
See Notes§
|
§ | ||||
Tdap or Td | Tdap: 1 dose each pregnancy| | 1 dose Tdap, then Td or Tdap booster every 10 yrs¶ | |||||||||
MMR | *# | # | |||||||||
VAR | *# | # | See Notes¶ | ¶ | |||||||
RZV | • | See Notes¶ | § | ||||||||
HPV | *# | 3-dose series if indicated§ | § | ||||||||
Pneumococcal | • | ¶ | § | ¶ | § | ||||||
HepA | § | • | ¶ | • | ¶ | • | |||||
HepB | See Notes | § | ¶ | § | ¶ | ¶ | ¶ | ||||
Age ≥ 60 years^ | |||||||||||
MenACWY | • | | | • | | | • | ||||||
MenB | ± | • | | | • | |||||||
Hib | • | HSCT: 3 dosesc| | • | Asplenia: 1 dose¶ | • | ||||||
Mpox | See Notes§ | § | See Notes§ | § | See Notes§ | ||||||
IPV | ± | Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)¶ |